Advertisement

Topics

Search Results for "Reminder Sample Letter Prostate Cancer"

08:33 EDT 21st July 2017 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Male cancer awareness

Cancer of the prostate is the most common cancer in men. The risk of prostate cancer increases with age and is quite rare in men under 50. One in eight men will get prostate cancer at some point in th...

Prostate Cancer Pipeline H1 2017 Therapeutic Key Players 3-V Biosciences Inc, 4SC AG, Actinium ...

Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms Read more...

Biomarker could lead to personalised therapies for prostate cancer

In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways clini...

Prostate cancer: ‘The prostate’ in patients with metastatic prostate cancer: to treat or not to treat?

Advances in understanding of prostate cancer biology and improved treatment options have changed management of metastatic prostate cancer. Escape of the malignancy from the prostatic capsule no longer...

Are men with a family history of prostate cancer eligible for active surveillance?

(Wiley) Active surveillance -- careful monitoring to determine if or when a cancer warrants treatment -- is an increasingly prevalent choice for prostate cancer, but it's unclear if the strategy is ap...

Prostate cancer treatment ‘could help more patients’ – BBC News

BBC NewsProstate cancer treatment 'could help more patients'BBC NewsOne of the largest clinical trials for prostate cancer has given "powerful results", say UK researchers. A drug for treating prostat...

It's Men's Health Month – Is Prostate Cancer Prevention Possible?

(PRWEB) June 25, 2017 June is Men’s Health Month and the focus is on prostate cancer. Second only to skin cancer, prostate ca...

Prostate cancer trial stuns researchers: ‘It’s a once in a career feeling’ – The Guardian

The GuardianProstate cancer trial stuns researchers: 'It's a once in a career feeling'The GuardianMore than 27,000 men in the US and 11,000 men in the UK die of prostate cancer each year. Photograph: ...

Matching PubMed Articles

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.

More than any other cancer, prostate cancer screening with the prostate-specific antigen (PSA) tests increases the risk a man will have to face a diagnosis of prostate cancer. The best evidence from s...

Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.

Intraductal carcinoma of the prostate (IDC-P) is a distinct histopathologic feature associated with high-grade, advanced prostate cancer. Although studies have shown that IDC-P is a predictor of progr...

A Survey of the Knowledge of African-American Women About Prostate Cancer Screening.

Prostate cancer is the second most common cancer diagnosed in men. Its incident and mortality rates are generally higher in populations of African descent. The scientific community recommends that men...

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Protective effects have been suggested for digoxin against prostate cancer risk. However, few studies have evaluated the possible effects on prostate cancer-specific survival. We studied the associati...

Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.

Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We recently identified a short ncRNA expressed from intron 1 of PCA3. Here we test the ability of this n...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement